Combined Endpoint Occurrence (%). Days From Randomization. No-PT - Placebo*PT- Clopidogrel*. . . 0. 5. 10. 0. 7. 14. 21. 28. PT = Pre-treatment*Plus ASA and other standard therapies. Death, MI, UTVR- PP Population. 18.5% RRRP=0.23. . 9. 8. 1. 4. 3. 2. 7. 6. 8.3%. 6.8%. . . . . . . . . . . . .
Related searches for Overall Study Design
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.